PhRMA is attempting to train and motivate pharmaceutical company employees to defend the industry and promote the value of medicines through its PharmaCorps workshops. Warren Ross finds out how the program works

Some retired folks play golf all day; others travel. But there’s something about healthcare communication execs that makes them not want to quit. Instead of retiring, they start a new career.

If healthcare communicators ever look for a patron saint, I nominate St. Sebastian, sentenced to have archers shoot arrows at him from all directions.

While big pharma scrambles to meet the demands of shareholders, Warren Ross looks at how two nonprofit drug firms—PolyTherics and OneWorld Health—are attempting to upset the patent cart

We all know that if you live on McDonald’s hamburgers for a month you’ll turn grossly obese, your “bad” cholesterol level will zoom and your liver will deteriorate.

It will be an interesting month for the drug approval process, with Federal Circuit Court, FDA and Congress all considering whether terminally ill patients should have wider access to unapproved drugs.

Just what do you think you’re doing? That maternal admonition might well be addressed by Mother Nature to the geneticists and biochemists whose research promises not just “to add a trait here or to subtract a defect here, but to alter radically our very being.”

The recent Institute of Medicine report pointed its institutional finger at the FDA over a variety of shortcomings surrounding drug safety post-marketing surveillance. Warren Ross reports on the potential ramifications for the pharmaceutical industry

Sens. Frist and Clinton are both on record as supporting the push for computerizing medical record keeping.

Imagine (we all have bad dreams from time to time) that you’ve been appointed FDA Commissioner.